| Q48234000 | A decade of experience with deep brain stimulation for patients with refractory medial temporal lobe epilepsy. |
| Q30882380 | A review of functional neuroimaging studies of vagus nerve stimulation (VNS). |
| Q33506685 | Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit |
| Q47679297 | Analysis of RR variability in drug-resistant epilepsy patients chronically treated with vagus nerve stimulation |
| Q55380555 | Anatomo-Physiologic Basis for Auricular Stimulation. |
| Q41334331 | Burn-induced organ dysfunction: vagus nerve stimulation improves cardiac function |
| Q87880385 | Calibration of thresholds for functional engagement of vagal A, B and C fiber groups in vivo |
| Q81523385 | Cardiac vagal tests and vagus nerve stimulation in epilepsy |
| Q34590975 | Chronic disorders with episodic manifestations: focus on epilepsy and migraine |
| Q42680030 | Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure |
| Q46336435 | Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics |
| Q35893397 | Complete heart block with ventricular asystole during left vagus nerve stimulation for epilepsy |
| Q37172696 | Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders |
| Q37611745 | Consultation-liaison psychiatry: how far have we come? |
| Q37146498 | Controlling bursting in cortical cultures with closed-loop multi-electrode stimulation |
| Q26747469 | Current Approaches to Neuromodulation in Primary Headaches: Focus on Vagal Nerve and Sphenopalatine Ganglion Stimulation |
| Q35757913 | Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices |
| Q48334915 | Daytime vigilance and quality of life in epileptic patients treated with vagus nerve stimulation |
| Q37609418 | Economic aspects of epilepsy and antiepileptic treatment: a review of the literature |
| Q36986229 | Effect of vagus nerve stimulation in post-traumatic epilepsy and failed epilepsy surgery : preliminary report |
| Q99562369 | Efficacy of vagus nerve stimulation for drug-resistant epilepsy in children age six and younger |
| Q30925819 | Epilepsy and depression: imaging potential common factors |
| Q37419977 | Epilepsy treatment as a predeterminant of psychosocial ill health |
| Q44519426 | Episodic phrenic-inhibitory vagus nerve stimulation paradoxically induces phrenic long-term facilitation in rats |
| Q35817272 | Expanding therapeutic options: devices and the treatment of refractory epilepsy |
| Q40364710 | Gastric acid secretion and gastrin release during continuous vagal neuromonitoring in thyroid surgery. |
| Q47417876 | Health Care Utilization Following Vagus Nerve Stimulation Therapy in Pediatric Epilepsy Patients From a Pediatric Accountable Care Organization |
| Q84365742 | Impact of continuous intraoperative neuromonitoring on autonomic nervous system during thyroid surgery |
| Q45057748 | Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy |
| Q50311461 | Lack of effects of vagus nerve stimulation on drug-resistant epilepsy in eight pediatric patients with autism spectrum disorders: a prospective 2-year follow-up study |
| Q40107695 | Long term effect of vagus nerve stimulation in pediatric intractable epilepsy: an extended follow-up |
| Q38313519 | Long-Term Outcome of Vagus Nerve Stimulation for Refractory Epilepsy: A Longitudinal 4 year Follow-up Study in Korea |
| Q30810993 | Neuroprotection trek--the next generation: neuromodulation I. Techniques--deep brain stimulation, vagus nerve stimulation, and transcranial magnetic stimulation |
| Q36462577 | Neurostimulation in resistant depression |
| Q47258557 | Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study |
| Q39205363 | Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet |
| Q39855109 | Outcome of vagus nerve stimulation for epilepsy in Budapest. |
| Q48198761 | Proportional feedback stimulation for seizure control in rats |
| Q37309895 | Prospective tests on biological models of acupuncture |
| Q53146871 | Quality of life and seizure outcome after vagus nerve stimulation in children with intractable epilepsy. |
| Q36419584 | Refractory epilepsy: mechanisms and solutions |
| Q34336700 | Rehospitalization and emergency department use rates before and after vagus nerve stimulation for epilepsy: use of state databases to provide longitudinal data across multiple clinical settings |
| Q92719711 | Research progress of vagus nerve stimulation in the treatment of epilepsy |
| Q38174933 | Safety of neural monitoring in thyroid surgery |
| Q35042687 | Stimulation of the nervous system for the management of seizures: current and future developments |
| Q56669510 | The Role of the Vagus Nerve in Cancer Prognosis: A Systematic and a Comprehensive Review |
| Q38915065 | The potential of ultrasound in cardiac pacing and rhythm modulation |
| Q35161337 | The recognition and management of mood disorders as a comorbidity of epilepsy |
| Q55290441 | Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias. |
| Q36827439 | Transcranial and deep brain stimulation approaches as treatment for depression |
| Q36314948 | VNS and depression: current status and future directions |
| Q38754855 | VNS and pregnancy: A multicentric experience of four cases. |
| Q36525864 | Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children |
| Q33865310 | Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia |
| Q38185559 | Vagal stimulation in heart failure. |
| Q27025730 | Vagomimetic effects of fingolimod: physiology and clinical implications |
| Q61805190 | Vagus Nerve Stimulation for Depression: A Systematic Review |
| Q57435819 | Vagus nerve stimulation for depression: efficacy and safety in a European study |
| Q36906895 | Vagus nerve stimulation for depression: rationale, anatomical and physiological basis of efficacy and future prospects. |
| Q37949779 | Vagus nerve stimulation for epilepsy: the notre-dame hospital experience. |
| Q47717730 | Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex |
| Q60910028 | Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial |
| Q51717725 | Vagus nerve stimulation for pharmacoresistant epilepsy: clinical symptoms with end of service. |
| Q48628406 | Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran. |
| Q35943658 | Vagus nerve stimulation in the treatment of epilepsy |
| Q36352575 | Vagus nerve stimulation use and effect in epilepsy: what have we learned? |
| Q48774739 | Vagus nerve stimulation: effectiveness and tolerability in patients with epileptic encephalopathies |
| Q37821801 | Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. |
| Q35486556 | Vagus nerve stimulation: predictors of seizure freedom |
| Q53856309 | [Electric brain stimulation for epilepsy therapy]. |